RSM Trademark

Trademark Overview


On Monday, January 31, 2022, a trademark application was filed for RSM with the United States Patent and Trademark Office. The USPTO has given the RSM trademark a serial number of 97247033. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 4, 2024. This trademark is owned by Finch Therapeutics, Inc.. The RSM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, immunotherapeutics, and therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders...
rsm

General Information


Serial Number97247033
Word MarkRSM
Filing DateMonday, January 31, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, immunotherapeutics, and therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFinch Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events


Event DateEvent Description
Thursday, November 10, 2022ASSIGNED TO EXAMINER
Thursday, February 3, 2022NEW APPLICATION ENTERED
Monday, February 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 18, 2022NON-FINAL ACTION WRITTEN
Friday, November 18, 2022NON-FINAL ACTION E-MAILED
Friday, November 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 19, 2024NON-FINAL ACTION WRITTEN
Monday, June 26, 2023SUSPENSION LETTER WRITTEN
Monday, June 26, 2023LETTER OF SUSPENSION E-MAILED
Monday, June 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 19, 2024NON-FINAL ACTION E-MAILED
Monday, February 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, June 4, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE